Trial Profile
A Multicenter, Randomized, Blinded, Placebo-Controlled Study To Evaluate The Safety Of Maraviroc In Combination With Other Antiretroviral Agents In HIV-1-Infected Subjects Co-Infected With Hepatitis C And/Or Hepatitis B Virus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2021
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors ViiV Healthcare
- 28 Apr 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 09 Oct 2012 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Oct 2012 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.